Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.

Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.

http://www.wikidata.org/entity/Q37247452

about

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Fundament and Prerequisites for the Application of an Antifungal TDM Service Antifungal pharmacokinetics and pharmacodynamics Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.Overlapping and distinct roles of Aspergillus fumigatus UDP-glucose 4-epimerases in galactose metabolism and the synthesis of galactose-containing cell wall polysaccharides.Posaconazole: a review of the gastro-resistant tablet and intravenous solution in invasive fungal infections.Invasive fungal infections: managing the continuum of risk in HCT patients.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.Pharmacokinetics of posaconazole in koalas (Phascolarctos cinereus) after intravenous and oral administration.Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity.Uptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.Posaconazole concentrations in human tissues after allogeneic stem cell transplantation.Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench story.Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.Urinary tract aspergillosis in a patient with chronic kidney disease.Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients.A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.

P2860

Q26771180-0F3F2D12-5ACC-42EA-AB7F-26E964CBFC26 Q27009221-E26E391C-B0A0-46CC-9C42-3CD59DFAC0C9 Q28085352-D69F90B0-94FA-4A84-B70F-DA11C1C9D042 Q35663841-15477F26-8A01-41DA-9FA3-04EDE667752D Q37203849-7AFC7056-F248-4B17-AF77-39A35275235F Q37488408-B77D160F-F4EB-43E7-8A53-2E9839736CE0 Q38321383-E77F44BD-45CE-4E56-A854-18BAE5C8A73C Q38661492-5CAABF63-89BF-4E01-8973-E9231B51D894 Q38681635-A5EB4362-10BE-46C9-B085-553F84315D79 Q38734661-04312448-7BE6-4135-B9B4-EAE1412E5375 Q38813173-916A010C-7D29-49D9-B1BF-A71A2D6557AA Q40164444-95562979-CBA7-45CA-91F2-857F52334BDC Q40396776-4712FA32-1698-468A-B0F2-70A44E78C957 Q41886285-041265A2-3907-4331-989E-52CD7E2D14D1 Q42385111-B9A29BED-4CAA-4B4E-A846-184394688A95 Q47115930-762975ED-ED16-4C18-9CF1-9605596D1355 Q47127046-C4F0BD09-5618-44E6-A308-D8AFAAA459BB Q48118247-92A0DE24-4433-46E4-9152-ADF57A70CAA6 Q55479804-77E3D769-8146-4D35-A7C6-70E782BBB3A1

P2860

Pharmacokinetics of posaconazole within epithelial cells and fungi: insights into potential mechanisms of action during treatment and prophylaxis.

http://www.wikidata.org/entity/Q37247452

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@en

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@nl

type

label

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@en

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@nl

prefLabel

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@en

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@nl

P1433

Q37247452-62D8D102-E3D0-4776-B83A-9A0C05FBAC0E

P1476

Q37247452-05FDA421-A3AF-4FF9-86D7-8942D56DE686

P2093

Q37247452-3B71C755-2EE1-4B62-AF4F-C3D2278D9632

Q37247452-78125D6C-30F8-44F3-94FC-7FD02D933F7F

Q37247452-B3C022F2-2096-4451-9574-F3D0291D523C

Q37247452-E4F4D463-5A1C-4CD1-B0F4-9F12AEEB6C2B

Q37247452-F5D378D0-E294-43C5-94A7-DBAB1B31EEC7

Q37247452-F75ECA3B-69C4-4C3A-8FBA-2D204449EBBA

P2860

Q37247452-0B329E2C-1F97-4B62-901A-C4E56B7F8087

Q37247452-0B92A55C-19EE-4580-B2BF-3B3223D275D6

Q37247452-1A0074FE-BAD8-428C-AEAA-F8C256FA1BB5

Q37247452-26008FFF-5D2F-4AD6-BB77-1B628C32546B

Q37247452-2F7E0BD0-DC5C-4EEE-8EAF-AE3C09F5C4AF

Q37247452-30D92AF9-B22C-44E4-9BC9-63D48E3261B1

Q37247452-43597CF6-6CEF-4313-8D41-24AE45651C95

Q37247452-48735CFE-899B-49F9-9AB1-8CCE31468EF3

Q37247452-4D3AA812-885C-4018-8F50-1CAF838E4FFD

Q37247452-4F05A317-213F-4F1D-A0B8-3A21BD629BAE

P304

Q37247452-750A53BA-A344-4EC3-8D80-D64D32E4378D

P31

Q37247452-D02A2352-D825-40A8-865B-638F5067A592

P356

Q37247452-8C861DD4-0119-4576-BDCD-0022C9954B84

P407

Q37247452-844FADF9-69FC-4C17-9BA2-F01F6B659F42

P433

Q37247452-D02AA1E0-81EC-406E-BF19-3525DAAA489C

P478

Q37247452-6684AD88-F5CA-4E7C-95DF-9346137E3F76

P577

Q37247452-9CFE83FF-A078-4EE3-B219-CD473EC6BD4E

P5875

Q37247452-9DBBA540-0594-44EE-8810-8CBA0606CBB9

P698

Q37247452-578D4157-B044-46EB-9D29-5408A22FC7D0

P921

Q37247452-4672008F-93E6-4EB8-A7A7-3538E6E75819

Q37247452-AF2D3348-1132-4CC8-AFFB-2D1E91E48480

P932

Q37247452-9BC1D08E-71E8-4F69-851E-3D6669B8076B

P356

P1433

The Journal of Infectious Diseases

P1476

Pharmacokinetics of posaconazo ...... ing treatment and prophylaxis.

@en

P2093

Arnold S Kristof

http://www.w3.org/2001/XMLSchema#string

David S Perlin

http://www.w3.org/2001/XMLSchema#string

Donald C Sheppard

http://www.w3.org/2001/XMLSchema#string

Paolo Campoli

http://www.w3.org/2001/XMLSchema#string

Scott G Filler

http://www.w3.org/2001/XMLSchema#string

Theodore C White

http://www.w3.org/2001/XMLSchema#string

P2860

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi

Intracellular concentrations of posaconazole in different compartments of peripheral blood.

Steady-state intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole in lung transplant recipients.

Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B.

Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

P304

1717-1728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIT358

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254281004

http://www.w3.org/2001/XMLSchema#string

P698

23908482

http://www.w3.org/2001/XMLSchema#string

P921

14-alpha sterol demethylase

Conidial hydrophobin

P932

3805237

http://www.w3.org/2001/XMLSchema#string